Virtus LifeSci Biotech Clinical Trials ETF
16 hedge funds and large institutions have $1.27M invested in Virtus LifeSci Biotech Clinical Trials ETF in 2023 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 3 increasing their positions, 5 reducing their positions, and 2 closing their positions.
Holders
16
Holders Change
-1
Holders Change %
-5.88%
% of All Funds
0.26%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
3
Reduced
5
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Citadel Advisors
Miami,
Florida
|
$697K |
| 2 |
2
Morgan Stanley
New York
|
$128K |
| 3 |
3
UBS Group
Zurich,
Switzerland
|
$30K |
| 4 |
4
Wells Fargo
San Francisco,
California
|
$6.32K |
